AllianceBernstein
ADPT icon

AllianceBernstein’s Adaptive Biotechnologies ADPT Stock Holding History

AllianceBernstein’s Portfolio ADPT Stock Details ADPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.97M Sell
121,228
-38,362
-24% -$611K ﹤0.01% 2013
2025
Q4 		$2.59M Buy
159,590
+3,300
+2% +$53.9K ﹤0.01% 1860
2025
Q3 		$2.34M Buy
156,290
+4,100
+3% +$50K ﹤0.01% 1916
2025
Q2 		$1.77M Buy
152,190
+39,200
+35% +$356K ﹤0.01% 1997
2025
Q1 		$840K Sell
112,990
-13,507
-11% -$104K ﹤0.01% 2328
2024
Q4 		$758K Sell
126,497
-1,890
-1% -$10.4K ﹤0.01% 2457
2024
Q3 		$657K Sell
128,387
-10,410
-8% -$45.4K ﹤0.01% 2530
2024
Q2 		$502K Buy
138,797
+19,601
+16% +$62.2K ﹤0.01% 2666
2024
Q1 		$383K Sell
119,196
-12,170
-9% -$47.1K ﹤0.01% 2705
2023
Q4 		$644K Sell
131,366
-830
-0.6% -$3.79K ﹤0.01% 2484
2023
Q3 		$720K Hold
132,196
– – ﹤0.01% 2385
2023
Q2 		$887K Hold
132,196
– – ﹤0.01% 2341
2023
Q1 		$1.17M Hold
132,196
– – ﹤0.01% 2146
2022
Q4 		$1.01M Hold
132,196
– – ﹤0.01% 2268
2022
Q3 		$941K Sell
132,196
-6,625
-5% -$62.4K ﹤0.01% 2317
2022
Q2 		$1.12M Buy
138,821
+95,267
+219% +$838K ﹤0.01% 2288
2022
Q1 		$605K Sell
43,554
-1,133
-3% -$17.8K ﹤0.01% 2603
2021
Q4 		$1.25M Sell
44,687
-3,849
-8% -$118K ﹤0.01% 2372
2021
Q3 		$1.65M Sell
48,536
-862
-2% -$31.2K ﹤0.01% 2268
2021
Q2 		$2.02M Buy
49,398
+6,335
+15% +$246K ﹤0.01% 2187
2021
Q1 		$1.73M Buy
43,063
+412
+1% +$22.3K ﹤0.01% 2176
2020
Q4 		$2.52M Buy
42,651
+4,650
+12% +$240K ﹤0.01% 1846
2020
Q3 		$1.85M Buy
38,001
+4,250
+13% +$179K ﹤0.01% 1893
2020
Q2 		$1.63M Buy
33,751
+3,930
+13% +$143K ﹤0.01% 1955
2020
Q1 		$828K Buy
29,821
+3,730
+14% +$104K ﹤0.01% 2115
2019
Q4 		$781K Buy
26,091
+11,890
+84% +$341K ﹤0.01% 2375
2019
Q3 		$439K Sell
14,201
-60,799
-81% -$2.48M ﹤0.01% 2619
2019
Q2 		$3.62M Buy
+75,000
New +$3.32M ﹤0.01% 1618

Other funds holding ADPT

Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

AllianceBernstein's ADPT Position: Q1 2026 in Review

AllianceBernstein reduced its Adaptive Biotechnologies (ADPT) stake by 24% in Q1 2026, selling an estimated $611K and leaving 121,228 shares worth $1.97M. The position accounts for ﹤0.01% of the portfolio, ranked #2013.

AllianceBernstein first reported a position in ADPT in Q2 2019 and has held it in 28 quarters since. The position peaked at $3.62M in Q2 2019. 295 funds tracked by Wall St. Rank hold ADPT as of Q1 2026.

  • AllianceBernstein held 121,228 shares of Adaptive Biotechnologies worth $1.97M as of Q1 2026.
  • AllianceBernstein sold 38,362 Adaptive Biotechnologies shares in Q1 2026, an estimated $611K.
  • Adaptive Biotechnologies made up ﹤0.01% of AllianceBernstein's portfolio in Q1 2026, its #2013 holding.
  • AllianceBernstein first reported a position in Adaptive Biotechnologies in Q2 2019 and has held it in 28 quarters since.
  • AllianceBernstein's Adaptive Biotechnologies position peaked at $3.62M in Q2 2019.
  • 295 funds tracked by Wall St. Rank held Adaptive Biotechnologies as of Q1 2026.

Based on AllianceBernstein's 13F filing for Q1 2026, filed 15 May 2026.